Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.524ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.15.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.59 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.193ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.68 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.84 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.15 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
XBC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.2 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
M.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.82 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used